Multifocal Motor Neuropathy Clinical Trials

27 clinical trials for Multifocal Motor Neuropathy across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Assess the Effect of Empasiprubart on Nerve Morphology by Ultrasound in Adults With Multifocal Motor Neuropathy — RECRUITING · PHASE1
• A PHASE 3, RANDOMIZED, DOUBLE-BLINDED, DOUBLE-DUMMY STUDY EVALUATING THE EFFICACY AND SAFETY OF EMPASIPRUBART VERSUS INTRAVENOUS IMMUNOGLOBULIN IN ADULTS WITH MULTIFOCAL MOTOR NEUROPATHY — RECRUITING · PHASE3
• A PHASE 2, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, STUDY TO EVALUATE SAFETY, TOLERABILITY, PHARMACOMETRICS, AND EFFICACY OF DNTH103 IN ADULTS WITH MULTIFOCAL MOTOR NEUROPATHY (MOMENTUM) — RECRUITING · PHASE2
• Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study — RECRUITING
• A PHASE 2, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER TRIAL TO EVALUATE THE SAFETY AND TOLERABILITY, EFFICACY, PHARMACOKINETICS, PHARMACODYNAMICS, AND IMMUNOGENICITY OF 2 DOSE REGIMENS OF ARGX-117 IN ADULTS WITH MULTIFOCAL MOTOR NEUROPATHY — RECRUITING · PHASE2
• A Randomized, Double-Blind, Placebo Controlled, Cross-over Study of the Effectiveness of Immune Globulin Intravenous (Human), 10% (IGIV, 10%) for the Treatment of Multofocl Motor Neuropathy — COMPLETED · PHASE3
• A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy — ACTIVE_NOT_RECRUITING · PHASE2
• A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN) — COMPLETED · PHASE3
• AN OPEN-LABEL, SINGLE-ARM, PHASE 1B STUDY TO EVALUATE THE EFFECT OF EMPASIPRUBART ON NERVE MORPHOLOGY BY ULTRASOUND IN ADULTS WITH MULTIFOCAL MOTOR NEUROPATHY — NOT_YET_RECRUITING · PHASE1
• A Phase 3, Randomized, Double-Blinded, Double-Dummy Study Evaluating the Efficacy and Safety of Empasiprubart Versus Intravenous Immunoglobulin in Adults With Multifocal Motor Neuropathy. — TERMINATED · PHASE3
• A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy — ACTIVE_NOT_RECRUITING
• A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy — ACTIVE_NOT_RECRUITING · PHASE3
• A Clinical Trial to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults With Multifocal Motor Neuropathy — COMPLETED · PHASE2
• A Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Study to Evaluate Safety, Tolerability, Pharmacometrics, and Efficacy of DNTH103 in Adults with Multifocal Motor Neuropathy (MOMENTUM) — TERMINATED · PHASE2
• A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy — ACTIVE_NOT_RECRUITING · PHASE2
• A Long-term Extension of the ARGX-117-2002 Trial to Evaluate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy — TERMINATED · PHASE2
• Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate Dosing — COMPLETED
• A LONG-TERM EXTENSION OF THE ARGX-117-2002 TRIAL TO EVALUATE THE LONG-TERM SAFETY AND TOLERABILITY, EFFICACY, PHARMACODYNAMICS, PHARMACOKINETICS, AND IMMUNOGENICITY OF ARGX-117 IN ADULTS WITH MULTIFOCAL MOTOR NEUROPATHY (MMN) — COMPLETED
• Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy — COMPLETED · PHASE3
• Efficacy and Safety of HyQvia (Immunoglobulin 10% With Recombinant Hyaluronidase) in Multifocal Motor Neuropathy (MMN) — COMPLETED · PHASE2
• HyQvia in Multifocal Motor Neuropathy — OTHER · NA
• Effect of Resistance and Aerobic Exercise in CIDP or MMN — COMPLETED · NA
• Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Multifocal Motor Neuropathy. — COMPLETED · PHASE3
• Immunoglobulin Dosage and Administration Form in CIDP and MMN — COMPLETED
• Change of Nerve Conduction Properties in IVIg Dependent Neuropathies — OTHER
• A Study of Purified Human Antibodies Administered Subcutaneously to Patients With Multifocal Motor Neuropathy (MMN) — COMPLETED · PHASE2
• Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy — COMPLETED · PHASE2

Refine this search